Queen Mary/Warwick Business School - Clinical red tape puts UK at risk

March 4, 2010

Delays and inconsistencies in the approval process for clinical research could be forcing pharmaceutical companies to look abroad, damaging the UK economy. That is the conclusion of new research by Queen Mary, University of London and Warwick Business School, which is based on a survey of around 250 clinical researchers. The two-year study, funded by the Engineering and Physical Sciences Research Council, found that retaining clinical staff is a growing problem for the country. It highlighted the difficulties that hampered researchers including obtaining approval from individual hospital trusts, and the variation in both the time and requirements needed to gain approval.

You've reached your article limit.

Register to continue

Registration is free and only takes a moment. Once registered you can read a total of 3 articles each month, plus:

  • Sign up for the editor's highlights
  • Receive World University Rankings news first
  • Get job alerts, shortlist jobs and save job searches
  • Participate in reader discussions and post comments
Register

Have your say

Log in or register to post comments